Hemoglobin News and Research

RSS
HemoBioTech receives patent for HemoTech treatment of acute blood loss

HemoBioTech receives patent for HemoTech treatment of acute blood loss

Discontinuing epoetin can normalize hemoglobin levels in hemodialysis patients

Discontinuing epoetin can normalize hemoglobin levels in hemodialysis patients

Super hemoglobin allows moles to grow underground

Super hemoglobin allows moles to grow underground

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

Gene therapy represents safe alternative to current cures for blood disorder β-thalassemia

Gene therapy represents safe alternative to current cures for blood disorder β-thalassemia

New research shows Alzheimer's disease may increase risk of other potentially disabling health conditions

New research shows Alzheimer's disease may increase risk of other potentially disabling health conditions

Simple, routine test for detecting subtle onset of diabetes and prediabetes

Simple, routine test for detecting subtle onset of diabetes and prediabetes

Rockwell Medical completes End of Phase II meeting with FDA regarding SFP

Rockwell Medical completes End of Phase II meeting with FDA regarding SFP

Study: ONGLYZA and metformin improve HbA1c levels for adult patients with type 2 diabetes at 76-weeks

Study: ONGLYZA and metformin improve HbA1c levels for adult patients with type 2 diabetes at 76-weeks

Shire presents positive data from TKT-025 EXT Phase I/II study for VPRIV in type 1 Gaucher disease patients

Shire presents positive data from TKT-025 EXT Phase I/II study for VPRIV in type 1 Gaucher disease patients

Studies on VIAject and Vialog presented at 70th American Diabetes Association sessions

Studies on VIAject and Vialog presented at 70th American Diabetes Association sessions

XOMA reaches enrollment goal of 325 patients for Phase 2b clinical trial of XOMA 052

XOMA reaches enrollment goal of 325 patients for Phase 2b clinical trial of XOMA 052

Medtronic's sensor-augmented insulin pump therapy provides superior glucose control, confirms STAR 3 study

Medtronic's sensor-augmented insulin pump therapy provides superior glucose control, confirms STAR 3 study

Study: Near-normal glucose control does not delay risk of organ damage in diabetes patients

Study: Near-normal glucose control does not delay risk of organ damage in diabetes patients

Sangart completes enrollment for MP4OX Phase IIa study in severely injured trauma patients

Sangart completes enrollment for MP4OX Phase IIa study in severely injured trauma patients

Study indicates two treatment strategies can reduce progression of diabetic retinopathy

Study indicates two treatment strategies can reduce progression of diabetic retinopathy

AMAG, Takeda provide regulatory and clinical update for Feraheme Injection

AMAG, Takeda provide regulatory and clinical update for Feraheme Injection

Dapagliflozin in addition to insulin improves glycemic control in type 2 diabetics

Dapagliflozin in addition to insulin improves glycemic control in type 2 diabetics

OrSense presents NBM 200 non-invasive Hb measurement system at XXXIst International Congress of ISBT

OrSense presents NBM 200 non-invasive Hb measurement system at XXXIst International Congress of ISBT

Masimo granted FDA clearance for Pronto-7 noninvasive hemoglobin spot-check testing device

Masimo granted FDA clearance for Pronto-7 noninvasive hemoglobin spot-check testing device